CKD-Associated Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020.

Kobo, Ofer; Abramov, Dmitry; Davies, Simon; Ahmed, Sofia B.; Sun, Louise Y.; Mieres, Jennifer H.; Parwani, Purvi; Siudak, Zbigniew; Van Spall, Harriette G.C.; Mamas, Mamas A.

Abstract

RATIONALE & OBJECTIVE: Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular (CV) mortality, but there are limited data on temporal trends disaggregated by sex, race, and urban/rural status in this population. STUDY DESIGN: Retrospective observational study. SETTING & PARTICIPANTS: The Centers for Disease Control and Prevention Wide-Ranging, Online Data for Epidemiologic Research database. EXPOSURE & PREDICTORS: Patients with CKD and end-stage kidney disease (ESKD) stratified according to key demographic groups. OUTCOMES: Etiologies of CKD- and ESKD-associated mortality between 1999 and 2000. ANALYTICAL APPROACH: Presentation of age-adjusted mortality rates (per 100,000 people) characterized by CV categories, ethnicity, sex (male or female), age categories, state, and urban/rural status. RESULTS: Between 1999 and 2020, we identified 1,938,505 death certificates with CKD (and ESKD) as an associated cause of mortality. Of all CKD-associated mortality, the most common etiology was CV, with 31.2% of cases. Between 1999 and 2020, CKD-related age-adjusted mortality increased by 50.2%, which was attributed to an 86.6% increase in non-CV mortality but a 7.1% decrease in CV mortality. Black patients had a higher rate of CV mortality throughout the study period, although Black patients experienced a 38.6% reduction in mortality whereas White patients saw a 2.7% increase. Hispanic patients experienced a greater reduction in CV mortality over the study period (40% reduction) compared to non-Hispanic patients (3.6% reduction). CV mortality was higher in urban areas in 1999 but in rural areas in 2020. LIMITATIONS: Reliance on accurate characterization of causes of mortality in a large dataset. CONCLUSIONS: Among patients with CKD-related mortality in the United States between 1999 and 2020, there was an increase in all-cause mortality though a small decrease in CV-related mortality. Overall, temporal decreases in CV mortality were more prominent in Hispanic versus non-Hispanic patients and Black patients versus White patients.

Citation

Kobo, O., Abramov, D., Davies, S., Ahmed, S. B., Sun, L. Y., Mieres, J. H., …Mamas, M. A. (2023). CKD-Associated Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020. KIDNEY MEDICINE, 5(3), Article 100597. https://doi.org/10.1016/j.xkme.2022.100597

• Journal Article Type: Article
• Acceptance Date: Dec 4, 2022
• Publication Date: Mar 1, 2023
• Journal: Kidney Medicine
• Print ISSN: 2590-0595
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 5
• Issue: 3
• Article Number: 100597
• DOI: https://doi.org/10.1016/j.xkme.2022.100597
• Publisher URL: https://www.kidneymedicinejournal.org/article/S2590-0595(22)00230-8/fulltext